chartexchange

NKTX
Nkarta, Inc. Common Stock
stockNASDAQ

Market OpenNov 17, 2026 11:36:23 AM EST
1.21USD-0.413%(-0.00)417,728
Pre-marketNov 17, 2026 9:00:30 AM EST
1.22USD+0.826%(+0.01)
1.2000Bid1.2100Ask0.0100Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
South San Francisco, CA, USA
Previous Close
$1.22
Beta
1.90
52-Week High
$3.72 2026-07-09
52-Week Low
$1.11 2026-11-13
SMA 50
$2.17
SMA 200
$2.49
Avg. Vol 10D
2.09M
Avg. Vol 30D
1.46M
Avg. Vol 90D
883,980
Relative Vol
0.29
57.63M
0.4200%
1,671
NKTX Profile

nkarta therapeutics seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies. nkarta was founded on the proprietary, robust and well characterized natural killer (nk) cell expansion technology pioneered by dario campana. the company is focused on leveraging the natural potent power of nk cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. nkarta is combining its nk expansion platform technology with proprietary cell engineering technologies to build differentiated autologous and allogeneic cell therapy candidates for the treatment of cancer. founded in 2015, the company's investors include sr one, nea and novo ventures. for more information, please visit the company's website at www.nkartatx.com.

NKTX Performance
PeriodPriceDateChangeBeta
1W1.352026-11-10-11.11%2.641
1M1.802026-10-16-33.33%1.839
3M2.432026-08-17-50.62%1.850
6M2.682026-05-18-55.22%1.610
1Y1.812025-11-17-33.70%1.901
2Y2.492024-11-18-51.81%—
5Y17.512021-11-17-93.15%1.581
NKTX Stock Summary

Nkarta, Inc. Common Stock (NASDAQ:NKTX) stock price today is $1.20, and today's volume is 415,091. NKTX is down 0.826% today. The 30 day average volume is 1.46M. NKTX market cap is $85.95M with 71.62M shares outstanding.